Lincoln Pharmaceuticals has successfully launched a cough syrup ‘NAMCOLD-DX’, which contains Dextromethorphan Polistirex. This is an Extended Release, unique product of Novel Technology. ‘NAMCOLD-DX’ is designed for all age group of patient above 4 years. The product is time tested and many trials have been done and it is approved by Drug Controller General of India (DCGI).
Normal cough syrups are effective up to 3-4 hours, so in 24 hours the patient has to take the syrup 4 to 5 times. But, this innovative product ‘NAMCOLD-DX’ is extended release, so the drug releases periodically and therefore the patient has to take only 2 doses during 24 hours.
Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.
